MEDNAX Stock Forecast, Price & News

MEDNAX (NYSE:MD) Frequently Asked Questions

Is MEDNAX a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MEDNAX in the last twelve months. There are currently 1 sell rating, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MEDNAX stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MD, but not buy additional shares or sell existing shares.
View analyst ratings for MEDNAX or view top-rated stocks.

How has MEDNAX's stock price been impacted by COVID-19 (Coronavirus)?

MEDNAX's stock was trading at $13.99 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MD shares have increased by 90.4% and is now trading at $26.64.
View which stocks have been most impacted by COVID-19.

When is MEDNAX's next earnings date?

MEDNAX is scheduled to release its next quarterly earnings announcement on Thursday, February 17th 2022.
View our earnings forecast for MEDNAX.

How were MEDNAX's earnings last quarter?

MEDNAX, Inc. (NYSE:MD) issued its quarterly earnings data on Thursday, October, 28th. The company reported $0.46 earnings per share for the quarter, beating analysts' consensus estimates of $0.41 by $0.05. The company earned $493 million during the quarter, compared to analyst estimates of $480.04 million. MEDNAX had a trailing twelve-month return on equity of 12.99% and a net margin of 1.05%. The business's revenue was up 7.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.33 EPS.
View MEDNAX's earnings history.

What price target have analysts set for MD?

8 analysts have issued twelve-month price targets for MEDNAX's shares. Their forecasts range from $22.00 to $32.00. On average, they expect MEDNAX's share price to reach $27.88 in the next year. This suggests a possible upside of 4.6% from the stock's current price.
View analysts' price targets for MEDNAX or view top-rated stocks among Wall Street analysts.

Who are MEDNAX's key executives?

MEDNAX's management team includes the following people:

• Mark S. Ordan, Chief Executive Officer & Director
• Roger Mack Hinson, President
• C. Mark Richards, Chief Financial Officer & Executive Vice President
• Dominic J. Andreano, Secretary, Executive VP & General Counsel
• Nikos Nikolopoulos, Chief Strategy & Growth Officer, Executive VP

What is Mark S. Ordan's approval rating as MEDNAX's CEO?

6 employees have rated MEDNAX CEO Mark S. Ordan on Glassdoor.com. Mark S. Ordan has an approval rating of 34% among MEDNAX's employees. This puts Mark S. Ordan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of MEDNAX's key competitors?

Some companies that are related to MEDNAX include Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), R1 RCM (RCM), AMN Healthcare Services (AMN), Amedisys (AMED), LHC Group (LHCG), CorVel (CRVL), Tivity Health (TVTY) and Cross Country Healthcare (CCRN).
View all of MD's competitors.

What other stocks do shareholders of MEDNAX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MEDNAX investors own include NVIDIA (NVDA), AbbVie (ABBV), QUALCOMM (QCOM), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walt Disney (DIS), Wells Fargo & Company (WFC), Exxon Mobil (XOM) and Advanced Micro Devices (AMD).

What is MEDNAX's stock symbol?

MEDNAX trades on the New York Stock Exchange (NYSE) under the ticker symbol "MD."

Who are MEDNAX's major shareholders?

MEDNAX's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.60%), Alliancebernstein L.P. (7.61%), Starboard Value LP (6.84%), Dimensional Fund Advisors LP (4.36%), ArrowMark Colorado Holdings LLC (3.10%) and New York State Common Retirement Fund (1.90%). Company insiders that own MEDNAX stock include John C Pepia, Mark S Ordan, Nicholas J Nikolopoulos, Roger Mack Hinson and Roger Md Medel.
View institutional ownership trends for MEDNAX.

Which institutional investors are selling MEDNAX stock?

MD stock was sold by a variety of institutional investors in the last quarter, including Starboard Value LP, BlackRock Inc., River Road Asset Management LLC, Invesco Ltd., Arrowstreet Capital Limited Partnership, Alliancebernstein L.P., Citigroup Inc., and ArrowMark Colorado Holdings LLC. Company insiders that have sold MEDNAX company stock in the last year include John C Pepia, Mark S Ordan, Roger Mack Hinson, and Roger Md Medel.
View insider buying and selling activity for MEDNAX or view top insider-selling stocks.

Which institutional investors are buying MEDNAX stock?

MD stock was bought by a variety of institutional investors in the last quarter, including Caas Capital Management LP, Allianz Asset Management GmbH, Morgan Stanley, Nordea Investment Management AB, Millennium Management LLC, New York State Common Retirement Fund, Cornercap Investment Counsel Inc., and Cubist Systematic Strategies LLC.
View insider buying and selling activity for MEDNAX or or view top insider-buying stocks.

How do I buy shares of MEDNAX?

Shares of MD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MEDNAX's stock price today?

One share of MD stock can currently be purchased for approximately $26.64.

How much money does MEDNAX make?

MEDNAX has a market capitalization of $2.30 billion and generates $1.73 billion in revenue each year. The company earns $-796.49 million in net income (profit) each year or $0.22 on an earnings per share basis.

How many employees does MEDNAX have?

MEDNAX employs 5,600 workers across the globe.

When was MEDNAX founded?

MEDNAX was founded in 1979.

What is MEDNAX's official website?

The official website for MEDNAX is www.mednax.com.

Where are MEDNAX's headquarters?

MEDNAX is headquartered at 1301 CONCORD TERRACE, SUNRISE FL, 33323.

How can I contact MEDNAX?

MEDNAX's mailing address is 1301 CONCORD TERRACE, SUNRISE FL, 33323. The company can be reached via phone at (954) 384-0175, via email at [email protected], or via fax at 954-838-9961.